Ecovec
Ecovec, a Belo Horizonte-based subsidiary of Rentokil Initial, operates the M.I.Aedes platform — combining smart traps, RT-PCR lab analysis, and georeferenced dashboards — to deliver subscription-based Aedes aegypti mosquito surveillance and arbovirus prevention services to Brazilian municipal and state health governments, with adjacent private-sector and research offerings.
- Company typePrivate
- Founded2002
- HeadquartersBelo Horizonte, Brazil
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Ecovec does
Ecovec is a Brazilian biotechnology company headquartered in Belo Horizonte, founded in 2002 and operating as a wholly-owned subsidiary of UK-based global pest control leader Rentokil Initial plc. The company builds and operates the M.I.Aedes (Monitoramento Integrado do Aedes) platform, an integrated Aedes aegypti mosquito surveillance system that combines purpose-built Mosquitrap smart traps (which selectively capture pregnant females using vegetable-infusion attractants), an internal molecular biology laboratory running RT-PCR arbovirus detection (dengue 1-4, zika, chikungunya) with 48-hour turnaround, and a georeferenced data platform delivering weekly IMFA/IPM infestation indices, viral circulation alerts, and predictive risk maps.
Ecovec's commercial model centers on annual subscription and managed-service contracts with Brazilian municipal and state health secretariats. Pricing is quote-based, sized to municipality coverage and number of traps; deployments are long-duration, with Porto Alegre operating continuously since 2012 (13+ years) and Espírito Santo monitored at state level (all 78 municipalities) since 2016. Documented outcomes include 27,191 dengue cases prevented in Minas Gerais with a 6:1 ROI and detection of DENV-2 five months before official circulation in Espírito Santo. Go-to-market is direct enterprise field sales augmented by health-conference participation (e.g., Cosens) and a WhatsApp-led inbound channel.
Ecovec has recently extended its offering beyond municipal public-sector monitoring. The M.I.Aedes Private Initiative targets corporate clients via the Rentokil umbrella, while Research Support Services sells traps and lab analysis to academic and clinical researchers. Strategic intent signals ongoing productization of its lab and data assets into adjacent customer segments, though headcount remains in the 11-50 range and revenue is not publicly disclosed.
Ecovec firmographics
Firmographics- Name
- Ecovec
- Legal name
- Ecovec
- Website
- https://ecovec.com
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Ecovec, a Belo Horizonte-based subsidiary of Rentokil Initial, operates the M.I.Aedes platform — combining smart traps, RT-PCR lab analysis, and georeferenced dashboards — to deliver subscription-based Aedes aegypti mosquito surveillance and arbovirus prevention services to Brazilian municipal and state health governments, with adjacent private-sector and research offerings.
- Ownership category
- akta.pro rank
Ecovec industry classification
Industry- Product category
- Public Health Vector Surveillance
- NAICS
- Exterminating and Pest Control Services (561710), Exterminating and Pest Control Services (56171)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Vector-Borne Disease Surveillance & Control (HLAJABAG)
Keywords
Where Ecovec is headquartered
LocationHeadquarters
- HQ city
- Belo Horizonte
- HQ country
- Brazil
- HQ region
- Latin America
Offices1 record
Markets served
Ecovec business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- Government Monitoring Services: Ecovec provides municipalities and state governments with continuous mosquito monitoring services, including trap installation, weekly sample collection, laboratory analysis, and data reporting. The service operates as an annual contract with municipalities receiving weekly reports and technical support throughout the year.
- M.I.Aedes Technology Platform: Licensing of the M.I.Aedes monitoring platform with access to maps, automated reports, heat risk maps, alerts, and historical series for public health decision-making.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Custom government contracts based on municipality size and coverage requirements |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels7 records
Ecovec product offering
Product offeringCore offering
Ecovec provides integrated Aedes aegypti mosquito monitoring and arbovirus surveillance services built around its proprietary M.I.Aedes platform. The offering combines field-deployed Mosquitrap smart traps, georeferenced egg-count data collection, and a molecular biology lab using RT-PCR to detect dengue, Zika, chikungunya, and yellow fever viruses in trapped mosquitoes. Customers receive weekly digital reports (Dengue-Report) that map infestation hotspots and predict outbreak risk, enabling targeted vector-control action by municipal and state health authorities.
Product overview
Ecovec offers a unified product ecosystem centered on the M.I.Aedes (Monitoramento Integrado do Aedes) platform for integrated Aedes mosquito monitoring and arbovirus prevention. The core offering combines the Mosquitrap smart traps, a molecular biology laboratory for virus detection, georeferenced data dashboards, and the Dengue-Report inspection management module. Services extend to private sector clients and academic research partnerships, all operating under the Rentokil Group. The system generates weekly infestation reports, viral circulation alerts, and predictive analytics for outbreak prevention.
Differentiator
Problem solved
Functional benefit
Brands
- M.I.Aedes: Monitoramento Integrado do Aedes - Sistema de monitoramento de fêmeas grávidas do Aedes aegypti através de captura em armadilhas inteligentes, gerando índices de infestação confiáveis e relatórios semanais para prefeituras e gestores de saúde.
Products and services
- M.I.Aedes (Monitoramento Integrado do Aedes)
- Mosquitrap
- Dengue-Report Online dashboard delivering weekly monitoring reports with infestation hotspot maps and predictive outbreak indicators. Used by public health managers to prioritize vector-control resources and operational actions.
- M.I.Aedes Private Initiative
- Research Support Services
Quantifiable outcome
- 27,191 dengue cases prevented in Minas Gerais
- +4 more outcomes
Companies that use Ecovec
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles3 records
Ecovec technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature5 records
Ecovec partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Rentokil InitialflagshipEcovec is a subsidiary of Rentokil Initial, the world leader in pest control with over 95 years of market experience. This partnership provides access to advanced technologies, cutting-edge pest control research, and global operational expertise that strengthens Ecovec's mosquito monitoring capabilities and service delivery to Brazilian municipalities.
Scale indicators5 records
Recent moves7 records
Expansion highlights5 records
Ecovec competitors and assessment
Company assessmentEmerging players
- Premise Data: Premise uses crowdsourced smartphone data and AI for vector surveillance and outbreak risk modeling, including dengue. Competes in the analytics layer with Ecovec's predictive capabilities but lacks Ecovec's physical trap network and molecular lab validation.
- Verily (Debug Project): Alphabet's Verily developed the Debug Project using sterile insect technique and Wolbachia-bearing mosquitoes for Aedes population suppression. Represents a technology-driven alternative to Ecovec's surveillance-led approach, focused on biological control rather than data and lab diagnostics.
- World Mosquito Program: Non-profit deploying Wolbachia-infected Aedes mosquitoes across multiple countries to suppress dengue transmission. Represents an alternative public-health intervention model that competes for the same municipal health-budget pool, though biological rather than data-and-surveillance based.
Direct peers
- In2Care: In2Care develops trap-based mosquito control technology targeting Aedes aegypti, including the In2Care Mosquito Station. Ecovec's Mosquitrap and M.I.Aedes system competes on the same trap-based vector surveillance axis, though In2Care focuses more on lethal control and Ecovec on data-driven surveillance and viral detection.
- Avia-GIS: Avia-GIS provides geospatial intelligence and risk modeling for vector-borne diseases, including Aedes surveillance platforms for governments. Overlaps with Ecovec's predictive analytics and georeferenced data dashboard capabilities, serving a similar public-health customer base in Europe and internationally.
- BG-Mosquitaire: BG-Mosquitaire operates a trap-based Aedes monitoring and control network, particularly in France and Europe. Comparable operating model to Ecovec's M.I.Aedes (distributed traps + data platform + government contracts), though focused on European municipalities.
Broad incumbents
- Rentokil Initial plc: Parent company of Ecovec and a global pest control incumbent with operations in 90+ countries. Provides Ecovec with R&D and operational scale, but also competes in adjacent pest control segments and could in theory replicate surveillance offerings through other subsidiaries.
- Bayer (Environmental Science): Bayer's Environmental Science division supplies larvicides, adulticides, and integrated pest management solutions for mosquitoes, including public-health programs. Competes indirectly for the same municipal vector-control budget, though primarily through chemical control products rather than surveillance.
- Terminix Global Holdings: Global pest control incumbent (now part of Rentokil Initial post-2022 merger) with broad residential and commercial mosquito control services. Comparable end market (vector control for properties), but lacks Ecovec's deep public-health surveillance and viral-detection focus.
- BASF Professional & Specialty Solutions: BASF supplies vector control products (larvicides, adulticides) and integrated pest management solutions to public health programs. Competes for the same municipal vector-control budget pool as Ecovec, though via chemical products rather than surveillance services.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Ecovec social profiles
Digital presenceEcovec financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ecovec leadership team
Management profileNumber of profiles
Profiles2 records
Ecovec funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ecovec M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ecovec
What does Ecovec do?
Ecovec provides integrated Aedes aegypti mosquito monitoring and arbovirus surveillance services built around its proprietary M.I.Aedes platform. The offering combines field-deployed Mosquitrap smart traps, georeferenced egg-count data collection, and a molecular biology lab using RT-PCR to detect dengue, Zika, chikungunya, and yellow fever viruses in trapped mosquitoes. Customers receive weekly digital reports (Dengue-Report) that map infestation hotspots and predict outbreak risk, enabling targeted vector-control action by municipal and state health authorities.
Is Ecovec a public or private company?
Ecovec is a private company. It is classified as corporate owned and is currently operating.
When was Ecovec founded?
Ecovec was founded in 2002. It employs 11 to 50 people.
Where is Ecovec based?
Ecovec is headquartered in Belo Horizonte, Brazil, in the Latin America region.
How does Ecovec make money?
Two revenue lines are on record. Government Monitoring Services are the primary driver. The others are M.I.Aedes Technology Platform.
Who are Ecovec's main competitors?
Emerging players on record are Premise Data, Verily (Debug Project) and World Mosquito Program. Direct peers are In2Care, Avia-GIS and BG-Mosquitaire. Broad incumbents are Rentokil Initial plc, Bayer (Environmental Science), Terminix Global Holdings and BASF Professional & Specialty Solutions.
Does Ecovec have an API?
No public API is recorded for Ecovec.
What industry is Ecovec in?
Ecovec's product category is Public Health Vector Surveillance. Its primary akta.pro industry code is HLAJABAG, Vector-Borne Disease Surveillance & Control. Its NAICS code is 561710 and its SIC code is 2835.